Bright Minds Biosciences Inc. SEC filings DRUG
Bright Minds Biosciences Inc. has 180 filings in SEC EDGAR's recent list, going back to Oct 6, 2020. Its latest annual report, Form 40-F, was filed on Dec 23, 2025 for the period ended Sep 30, 2025. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 2, 2026 | Nov 2, 2026 |
| 6-K | Current report (foreign issuer) | Oct 2, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Oct 1, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 17, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jun 3, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jan 20, 2026 |
| 6-K | Current report (foreign issuer) | May 28, 2026 | May 26, 2026 |
| 6-K | Current report (foreign issuer) | May 20, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Feb 13, 2026 | Dec 31, 2025 |
| 6-K | Current report (foreign issuer) | Jan 9, 2026 | Jan 9, 2026 |
| 6-K | Current report (foreign issuer) | Jan 9, 2026 | Jan 7, 2026 |
| 6-K | Current report (foreign issuer) | Jan 8, 2026 | Jan 7, 2026 |
| 6-K | Current report (foreign issuer) | Jan 7, 2026 | Jan 7, 2026 |
| 6-K | Current report (foreign issuer) | Jan 7, 2026 | Jan 6, 2026 |
| 6-K | Current report (foreign issuer) | Jan 6, 2026 | Jan 6, 2026 |
| 6-K | Current report (foreign issuer) | Jan 5, 2026 | Jan 5, 2026 |
| 6-K | Current report (foreign issuer) | Nov 17, 2025 | Nov 17, 2025 |
| 6-K/A | Form 6-k/a | Nov 17, 2025 | Nov 6, 2025 |
| 6-K | Current report (foreign issuer) | Nov 7, 2025 | Oct 30, 2025 |
| 6-K | Current report (foreign issuer) | Nov 7, 2025 | Nov 6, 2025 |
| 6-K | Current report (foreign issuer) | Sep 5, 2025 | Sep 4, 2025 |
| 6-K | Current report (foreign issuer) | Aug 15, 2025 | Jun 30, 2025 |
| 6-K | Current report (foreign issuer) | Aug 11, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | May 28, 2025 | May 28, 2025 |
| 6-K | Current report (foreign issuer) | May 21, 2025 | May 20, 2025 |
| 6-K | Current report (foreign issuer) | May 14, 2025 | May 13, 2025 |
| 6-K | Current report (foreign issuer) | Apr 29, 2025 | Apr 28, 2025 |
| 6-K | Current report (foreign issuer) | Mar 5, 2025 | Mar 4, 2025 |
| 6-K | Current report (foreign issuer) | Feb 24, 2025 | Feb 24, 2025 |
| 6-K | Current report (foreign issuer) | Feb 14, 2025 | Dec 31, 2024 |
| 6-K | Current report (foreign issuer) | Jan 8, 2025 | Jan 7, 2025 |
| 6-K | Current report (foreign issuer) | Nov 21, 2024 | Nov 21, 2024 |
| 6-K | Current report (foreign issuer) | Nov 5, 2024 | Nov 4, 2024 |
| 6-K | Current report (foreign issuer) | Oct 21, 2024 | Oct 21, 2024 |
| 6-K | Current report (foreign issuer) | Oct 18, 2024 | Oct 18, 2024 |
| 6-K | Current report (foreign issuer) | Oct 16, 2024 | Oct 15, 2024 |
| 6-K | Current report (foreign issuer) | Oct 16, 2024 | Oct 16, 2024 |
| 6-K | Current report (foreign issuer) | Oct 3, 2024 | Oct 3, 2024 |
| 6-K | Current report (foreign issuer) | Sep 12, 2024 | Sep 12, 2024 |
| 6-K | Current report (foreign issuer) | Aug 15, 2024 | Jun 30, 2024 |
| 6-K | Current report (foreign issuer) | May 17, 2024 | Mar 31, 2024 |
| 6-K | Current report (foreign issuer) | May 17, 2024 | Mar 22, 2024 |
| 6-K | Current report (foreign issuer) | Feb 13, 2024 | Dec 31, 2023 |
| 6-K | Current report (foreign issuer) | Dec 26, 2023 | Dec 22, 2023 |
| 6-K | Current report (foreign issuer) | Dec 8, 2023 | Dec 6, 2023 |
| 6-K | Current report (foreign issuer) | Aug 15, 2023 | Jun 30, 2023 |
| 6-K | Current report (foreign issuer) | Aug 8, 2023 | Aug 8, 2023 |
| 6-K | Current report (foreign issuer) | Jul 20, 2023 | Jul 20, 2023 |
| 6-K | Current report (foreign issuer) | Jul 12, 2023 | Jul 12, 2023 |
| 6-K | Current report (foreign issuer) | Jun 22, 2023 | Jun 22, 2023 |
| 6-K | Current report (foreign issuer) | May 15, 2023 | Mar 31, 2023 |
| 6-K | Current report (foreign issuer) | Apr 19, 2023 | Apr 19, 2023 |
| 6-K | Current report (foreign issuer) | Apr 10, 2023 | Apr 10, 2023 |
| 6-K | Current report (foreign issuer) | Mar 2, 2023 | Mar 1, 2023 |
| 6-K | Current report (foreign issuer) | Feb 27, 2023 | Feb 27, 2023 |
| 6-K | Current report (foreign issuer) | Feb 17, 2023 | Feb 17, 2023 |
| 6-K | Current report (foreign issuer) | Feb 8, 2023 | Feb 8, 2023 |
| 6-K | Current report (foreign issuer) | Feb 7, 2023 | Dec 31, 2022 |
| 6-K | Current report (foreign issuer) | Jan 30, 2023 | Jan 9, 2023 |
| 6-K | Current report (foreign issuer) | Jan 27, 2023 | Jan 27, 2023 |
| 6-K | Current report (foreign issuer) | Dec 6, 2022 | Dec 2, 2022 |
| 6-K | Current report (foreign issuer) | Nov 29, 2022 | Nov 28, 2022 |
| 6-K | Current report (foreign issuer) | Nov 23, 2022 | Nov 23, 2022 |
| 6-K | Current report (foreign issuer) | Sep 8, 2022 | Sep 7, 2022 |
| 6-K | Current report (foreign issuer) | Sep 8, 2022 | Aug 31, 2022 |
| 6-K | Current report (foreign issuer) | Aug 30, 2022 | Aug 30, 2022 |
| 6-K | Current report (foreign issuer) | Aug 29, 2022 | Aug 26, 2022 |
| 6-K | Current report (foreign issuer) | Aug 24, 2022 | Aug 24, 2022 |
| 6-K | Current report (foreign issuer) | Aug 23, 2022 | Aug 23, 2022 |
| 6-K | Current report (foreign issuer) | Aug 18, 2022 | Aug 18, 2022 |
| 6-K | Current report (foreign issuer) | Aug 15, 2022 | Jun 30, 2022 |
| 6-K | Current report (foreign issuer) | May 16, 2022 | Mar 31, 2022 |
| 6-K | Current report (foreign issuer) | May 12, 2022 | May 12, 2022 |
| 6-K | Current report (foreign issuer) | May 2, 2022 | May 2, 2022 |
| 6-K | Current report (foreign issuer) | Apr 19, 2022 | Apr 19, 2022 |
| 6-K | Current report (foreign issuer) | Mar 14, 2022 | Mar 14, 2022 |
| 6-K | Current report (foreign issuer) | Mar 8, 2022 | Mar 8, 2022 |
| 6-K | Current report (foreign issuer) | Mar 2, 2022 | Mar 1, 2022 |
| 6-K | Current report (foreign issuer) | Feb 15, 2022 | Dec 31, 2021 |
| 6-K | Current report (foreign issuer) | Jan 5, 2022 | Jan 4, 2022 |
| 6-K | Current report (foreign issuer) | Nov 30, 2021 | Nov 30, 2021 |
| 6-K | Current report (foreign issuer) | Nov 3, 2021 | Nov 3, 2021 |
| 6-K | Current report (foreign issuer) | Oct 19, 2021 | Oct 6, 2021 |
| 6-K | Current report (foreign issuer) | Sep 27, 2021 | Sep 22, 2021 |
| 6-K | Current report (foreign issuer) | Sep 17, 2021 | Jun 30, 2021 |
| 6-K | Current report (foreign issuer) | Sep 17, 2021 | Sep 8, 2021 |
| 6-K | Current report (foreign issuer) | Aug 18, 2021 | Aug 18, 2021 |
Showing 87 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- DRUG (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- British Columbia, Canada
- Headquarters
- Chicago, IL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1827401
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.